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Class switch recombination (CSR) at the immuno-
globulin heavy-chain (IgH) locus is associated with
the formation of R-loop structures over switch (S) re-
gions. While these often occur co-transcriptionally
between nascent RNA and template DNA, we now
show that they also form as part of a post-transcrip-
tional mechanism targeting AID to IgH S-regions.
This depends on the RNA helicase DDX1 that is
also required for CSR in vivo. DDX1 binds to G-quad-
ruplex (G4) structures present in intronic switch
transcripts and converts them into S-region
R-loops. This in turn targets the cytidine deaminase
enzyme AID to S-regions so promoting CSR. Notably
R-loop levels over S-regions are diminished by
chemical stabilization of G4 RNA or by the expres-
sion of a DDX1 ATPase-deficient mutant that acts
as a dominant-negative protein to reduce CSR
efficiency. In effect, we provide evidence for how
S-region transcripts interconvert between G4 and
R-loop structures to promote CSR in the IgH locus.
INTRODUCTION
The mouse immunoglobulin heavy-chain (IgH) locus contains
a set of constant (CH) region exons, which span a genomic
sequence of approximately 220 kb and determine the isotype
and effector function of antibodies. B cells activated by antigen
undergo IgH class switch recombination (CSR), a DNA deletion
mechanism that replaces the default Cm constant region for
one of several downstream CH exons (Cg, Cε, or Ca) (Matthews
et al., 2014). This process is strictly dependent on non-coding
transcription initiated from intronic promoters located upstream
of each set of CH exons (Chaudhuri et al., 2003; Ramiro et al.,
2003). CSR long non-coding (lnc) RNAs are termed germline
transcripts (GLTs) and include a non-coding first exon, which is650 Molecular Cell 70, 650–662, May 17, 2018 ª 2018 The Author(s).
This is an open access article under the CC BY-NC-ND license (http://spliced to downstream CH exons. Distinct sets of cytokines
induce GLTs from distinct CH exons to promote CSR to that
particular isotype, while GLTs upstream of the Cm exon are pro-
duced constitutively (Stavnezer et al., 1988).
Transcription of each GLT first intron, which contain 1- to
10-kb-long sequences called switch (S) regions, promotes the
formation of R-loops (Daniels and Lieber, 1995; Reaban and
Griffin, 1990; Yu et al., 2003). These RNA:DNA hybrid structures
are formed between the G-rich and highly repetitive lncRNA and
the template DNA (Roy and Lieber, 2009; Roy et al., 2008; Zhang
et al., 2014). R-loop formation results in non-template single-
strand DNA (ssDNA) that may act as a substrate for activation-
induced cytidine deaminase (AID), the enzyme that initiates
CSR by deaminating cytidines to uracils (Chaudhuri et al.,
2003). Resulting U:G mismatches are subsequently processed
into DNA double-strand breaks (DSBs) by mismatch and base-
excision DNA repair proteins and two distinct S-regions are
ligated by non-homologous end-joining proteins (Matthews
et al., 2014).
In support of this R-loop mechanism, transgenic mouse
models showed that a synthetic DNA fragment with a G-rich
non-template strand can support CSR and inversion of Sg1 re-
duces R-loop formation and CSR to IgG1 (Shinkura et al.,
2003). Both the negative supercoiling imposed by a transcribing
polymerase (Parsa et al., 2012) and nascent RNA degradation by
the RNA exosome complex (Basu et al., 2011) have been pro-
posed to expose S-region DNA to deamination by AID. AID tar-
geting may rely on components of the transcription machinery
at sites of transcriptional stalling through AID association with
Spt5 (Pavri et al., 2010). Recent evidence also supports a
post-transcriptional, RNA-guided mechanism for the targeting
of AID to complementary S-region DNA. AID was demonstrated
to bind G-quadruplex (G4) structures present in mGLT and aGLT
introns and an AIDmutant unable to bind G4 RNA abolishes CSR
to IgG1 (Zheng et al., 2015). Notably, switch G4 RNAs were
shown to occur following intron lariat debranching catalyzed
by DBR1 (Zheng et al., 2015). These findings may explain earlier
observations implicating a direct role for GLT in CSR (Hein et al.,
1998; Lorenz et al., 1995; M€uller et al., 1998; Nowak et al., 2011).
It was shown that induction of spliced switch transcripts isPublished by Elsevier Inc.
creativecommons.org/licenses/by-nc-nd/4.0/).
sufficient to target CSR to IgG1, whereas transcription alone is
not (Lorenz et al., 1995). Possibly switch G4 RNA is closely regu-
lated during CSR, even though it remains unclear how these
highly structured RNAs can access DNA strands to target AID
to IgH S-regions.
Recently, it has been shown that G4 or branched DNA struc-
tures act as preferred AID targets in vitro based on structural
studies (Qiao et al., 2017). These reveal a bifurcated substrate
binding-surface for AID that simultaneously binds two single-
stranded sequences. Interestingly, AID appears to recognize
both DNA and RNA with similar affinities, which may explain
how AID binding to G4 RNA impacts on CSR (Pucella and
Chaudhuri, 2017; Zheng et al., 2015). The exact nature of struc-
tured AID substrates in vivo is unclear but may involve both
RNA and DNA counterparts (Pucella and Chaudhuri, 2017).
Consequently, AID targeting to S-regions may require DEAD-
box RNA helicase activity to reorganize G4 RNA and R-loop
structures.
DEAD-box proteins share a highly conserved helicase core
consisting of two RecA-like domains connected by a short
flexible linker that bind or remodel RNA and RNA-protein
complexes. They are characterized by at least 13 conserved
sequence motifs involved in ATP binding, ATP hydrolysis, and
RNA binding, including the Walker A motif I and Walker B
motif II Asp-Glu-Ala-Asp (DEAD) (Linder and Jankowsky,
2011). The DEAD-box RNA helicase 1 (DDX1) has been impli-
cated in various aspects of RNA metabolism including pre-
mRNA 30end processing (Ble´oo et al., 2001; Chen et al., 2002),
tRNA ligase catalyzed splicing (Jurkin et al., 2014; Popow
et al., 2014), mRNA transport (Kanai et al., 2004), RNA export
(Yasuda-Inoue et al., 2013), and the maturation of DNA dam-
age-induced micro-RNAs (Han et al., 2014). Also, DDX1 may
be part of the cellular response to DSBs occurring at sites of
active transcription where it was shown to be required for effi-
cient repair (Li et al., 2008, 2016). A role for DDX1 in the innate
immune response against viral infection has also been sug-
gested as DDX1 together with DDX21 and DHX36 acts as a
sensor of cytoplasmic double-strand RNA (dsRNA) (Zhang
et al., 2011). Since DDX1 was previously identified in pull-down
experiments using chromatin-bound AID as a bait (Willmann
et al., 2012), we elected to investigate its potential role in CSR.
We describe DDX1 as a critical effector of CSR that facilitates
AID targeting to S-region DNA. We further elucidate the molecu-
lar mechanism whereby DDX1 acts on intronic switch G4 RNA to
promote formation of S-region R-loops.
RESULTS
DDX1 Knockout Impairs CSR in B Cells
In the spleen, B cells that encounter antigen are activated to
proliferate as short-lived plasmablasts, undergo CSR and can
enter into germinal centers (GCs). In the GC, B cells further
differentiate into long-lived, antibody-secreting plasma cells.
To examine whether changes in DDX1 gene expression accom-
pany the differentiation of mature B cell subsets, we compared
DDX1mRNA levels in naive follicular B cells with activated plas-
mablasts, GC B cells and terminally differentiated plasma cells
(Braza˜o et al., 2016). Interestingly, DDX1 expression increased2-fold upon B cell activation and remained elevated in plasma
cells residing in the spleen or the bone marrow (Figure S1A).
This suggests that increased DDX1 expression occurs at stages
when B cells undergo CSR and differentiate into antibody-
secreting plasma cells.
To directly test whether DDX1 controls CSR we activated
splenic B cells ex vivo. Stimulation with bacterial lipopolysaccha-
ride (LPS) and LPS plus interleukin-4 (IL-4) induces naive B cell
proliferation, and switching from IgM to IgG3 and IgG1, respec-
tively. We observed induction of g3 and g1 GLT and a gradual
decrease in m GLT levels over 4 days (Figure S1B). Levels of
AID encoding Aicda mRNA, were also markedly increased.
Finally, a consistent increase in DDX1 protein levels upon
LPS or LPS plus IL-4 stimulation was detected at day 3 (Fig-
ure S1C). For deletion of DDX1 we treated B cells isolated from
DDX1loxP/loxP mice with recombinant TAT-Cre protein, which
caused efficient excision of DDX1 exon 5 from the genome (Fig-
ures 1A and 1B) and a near complete loss of DDX1 protein (Fig-
ure 1C). As CSR is linked to cell division (Hodgkin et al., 1996), we
labeled cells with the fluorescent cell tracking dye carboxyfluor-
escein succinimidyl ester (CFSE) to access CSR independently
of cell proliferation. Notably, a 2-fold reduction in surface IgG3
and IgG1 expression was observed in DDX1-deleted cells as
compared to control B cells (Figures 1D and 1E). This did not
result from impaired cell proliferation, as a similar decrease in
IgG1 CSR levels was observed in cells that underwent different
numbers of cell divisions (Figure 1F). We conclude that DDX1
is required for efficient CSR in primary B cells.
To further evaluate whether DDX1 is required for CSR in vivo,
we used B cell-specific conditional DDX1 knockout mice. These
were generated by expressing Cre recombinase specifically
in activated B cells (DDX1loxP/loxP Aicda-Cre+/, DDX1 cKO).
Consistent with a role for DDX1 in CSR, sera from DDX1 cKO
mice showed normal levels of IgM and a general decrease in
the steady-state levels of switched IgH isotypes compared to
wild-type (WT) mice (Figure 1G). Upon in vivo immunization
with ovalbumin (OVA) antigen in complete Freund’s adjuvant, an-
tigen-specific IgG responses were strongly increased inWT (Fig-
ure 1H). In contrast, serum levels of OVA-specific IgG were
reduced in immunized DDX1 cKO mice, whereas OVA-specific
IgM were slightly increased compared to WT (Figure 1H). Total
levels of switched IgH isotypes were also decreased in DDX1
cKO mice after immunization, including IgG1 and IgG2c isotype
that are strongly upregulated in WT mice (Figure S1D). Also, we
observed induction of GC B cells and plasmablasts after DDX1
cKO mice immunization, albeit less than WT controls (Figures
S1E and S1F). Remarkably, most plasmablasts in immunized
DDX1 cKO mice have not undergone switching and retained
expression of m IgH (Figure S1F). Yet, both WT and DDX1 cKO
splenocytes produce high levels of the switch-inducing cytokine
interferon (IFN)-g in response to OVA stimulation (Figure S1G).
Taken together, these results demonstrate that DDX1 deficiency
severely impairs CSR in vivo.
Transcription Is Largely Unaffected in DDX1-Depleted
B Cells
To better characterize how DDX1 controls CSR, we employed
the mouse CH12 cell line, which shows efficient IgM to IgAMolecular Cell 70, 650–662, May 17, 2018 651
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Figure 1. Impaired CSR in DDX1 Knockout B Cells
(A) Diagram of conditional DDX1 (DDX1loxP) and Cre-deleted DDX1 (DDX1del) alleles. PCR primers are indicated.
(B) PCR analysis of genomic DNA from DDX1loxP/loxP splenic B cells treated with TAT-Cre (2 replicates).
(C) Western blot of WT and DDX1-deleted (DDX1D) B cells (day 4, 2 replicates).
(D) Flow cytometric analysis for surface IgG3 and IgG1 expression and CFSE in WT and DDX1D B cells stimulated for 4 days.
(E) Quantification of CSR for cultures shown in (D). Each symbol represents B cell cultures from individual mice (nR 3, mean ± SD).
(F) Percentage of IgG1+ cells analyzed per number of cell divisions in CFSE-labeled LPS plus IL-4 cultures at day 4. One representative experiment with 3mice per
genotype (mean ± SD).
(G) Serum Ig concentrations in naive WT and DDX1 cKO mice. Each symbol represents individual mice and horizontal lines indicate the mean.
(H) Antigen-specific IgG and IgM immune responses in WT and DDX1 cKO mice immunized with ovalbumin (OVA) antigen. Serum was analyzed by ELISA and
endpoint titers were determined (n = 2, mean ± SD; 3–7 mice in each time point except week 10 where 2–3 mice were analyzed). See also Figure S1.CSR following cytokine induction (Nakamura et al., 1996). CH12
cells were stably depleted of DDX1 using lentivirus-expressing
short hairpin RNA (shRNA) (Figure 2A). CH12 cells transduced
with a control shRNA (non-targeting, shCtrl) efficiently switch
from IgM to IgA (50% IgA+IgM– cells), upon in vitro stimulation
with anti-CD40, IL-4, and TGF-b (CIT) for 72 hr (Figure 2B). In
contrast, DDX1 knockdown cell lines showed a 50% loss of
IgA+IgM– cells in CIT cultures (Figures 2B and 2C). In control
cells stimulated with CIT, we observed lower proliferation
when compared to unstimulated conditions, as reflected by
higher CFSE levels or lower dilution (Figure S2A). Cell-cycle
analysis revealed an increased proportion of CIT cells in the
G1-phase of the cell cycle (Figure S2B), likely due to AID-
induced mutations and DNA repair mechanisms associated
with CSR causing a G1 delay (Sharbeen et al., 2012). Surpris-652 Molecular Cell 70, 650–662, May 17, 2018ingly, knockdown of DDX1 resulted in increased proliferation
rates and increased proportions of cells in the S-phase of the
cell cycle upon CIT stimulation (Figures S2A and S2B). However,
based on the frequency of IgA+ cells as a function of CFSE dilu-
tion, we conclude that DDX1 is required for efficient CSR in
CH12 cells independently of cell proliferation (Figure S2C). We
also performed CRISPR/Cas9-mediated gene inactivation of
DDX1 (exon 5) in CH12 cells but no homozygous deletions
were obtained, suggesting that DDX1 is essential for viability
(Hildebrandt et al., 2015). A heterozygous clone with a frameshift
mutation leading to a premature stop codon (Figure S2D)
was obtained and expanded in culture. However, DDX1+/
CH12 cells show only a partial decrease in DDX1 protein levels
and no effect on CSR as compared to WT cells (Figures S2E
and S2F).
Figure 2. Transcription Profiling in DDX1-Depleted CH12 Cells
CH12 cells transduced with shCtrl or shDDX1 were analyzed after 72 hr in unstimulated (UNS) or CIT-stimulated conditions.
(A) Western blot for DDX1 and Tubulin loading control.
(B) Flow cytometric analysis for surface IgM and IgA expression.
(C) Quantification of CSR for CIT cultures shown in (B) (average of 2 clones for each shRNA; n > 3, mean ± SD).
(D) Quantitative PCR analysis of chRNA after 24 hr in UNS or CIT conditions. Unspliced mGLT and aGLT levels were normalized to unspliced b-actin transcript and
shCtrl UNS (n = 2, mean ± SD).
(E) Heatmap of 120 differentially expressed genes between shCtrl or shDDX1 CH12 cells in UNS or CIT conditions. Gene expression values (FPKM) are shown
(fold changeR2, false discovery rate [FDR]%0.05; n = 2). Hierarchical clustering identified 11 groups of genes (clusters I–XI) with similar patterns of expression
change across the different samples analyzed. See also Figure S2.To determine whether impaired CSR in DDX1-depleted
cells is associated with changes in gene transcription, we
analyzed nascent transcript levels in chromatin-associated
RNA (chRNA) from shCtrl and shDDX1 CH12 cells. The purity
of chRNA following nuclear fractionation was confirmed by
the presence of unspliced b-actin RNA in the chromatin but
not nucleoplasm fractions (Figure S2G). We next tested the
effect of DDX1 depletion on nascent GLT levels in chRNA (Fig-
ure 2D). mGLT levels were relatively unaffected by CIT stim-
ulation while aGLT increased significantly, consistent with
constitutive mGLT and cytokine-induced aGLT transcription
(Stavnezer et al., 1988). Of note, GLT levels were not substan-
tially affected by DDX1 depletion (Figure 2D). Next, we per-
formed high-throughput sequencing of chRNA (chRNA-seq)
to measure genome-wide gene expression changes in DDX1-
depleted CH12 cells. Most changes in differentially expressed
genes were observed between unstimulated and CIT-stimu-
lated conditions, irrespective of DDX1 knockdown (Figure 2E;
Table S1). The few genes that were differentially expressed be-
tween shCtrl and shDDX1 cells (Figure 2E, clusters VII and VIII)
were equally affected under unstimulated and CIT-stimulated
conditions. Overall, we demonstrate that DDX1 is requiredfor efficient CSR but does not affect gene expression levels
per se.
Decreased R-Loop Levels over IgH S-Regions in DDX1-
Depleted B Cells
Previous studies have reported the recruitment of DDX1 to sites
of DNA damage containing RNA:DNA hybrids, where it may facil-
itate homologous recombination (Li et al., 2008, 2016). Because
R-loop structures over S-regions have been implicated in CSR
(Shinkura et al., 2003; Yu et al., 2003), we evaluated R-loop levels
over IgH genomic regions using the S9.6 RNA:DNA hybrid-spe-
cific antibody in DNA immunoprecipitation (DIP) assays (Fig-
ure 3A). We show that RNA:DNA hybrids were specifically en-
riched in regions flanking the Sm repeats in unstimulated and
CIT-stimulated shCtrl cells (Figure 3B) or upstream the Sa re-
peats in CIT-stimulated shCtrl cells (Figure 3C), consistent with
previous studies (Huang et al., 2007; Kao et al., 2013). Note
that the S-region core repeats cannot be directly measured for
R-loops by PCR due to its repetitive sequence nature. Interest-
ingly, reduced R-loop levels were detected in Sm and Sa regions
in shDDX1 CH12 cells following CIT stimulation (Figures 3B and
3C). Similar results were obtained when DDX1 was transientlyMolecular Cell 70, 650–662, May 17, 2018 653
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Figure 3. Reduced R-Loop Levels over IgH S-Regions in DDX1-Depleted Cells
(A) Diagram of the mouse IgH locus. Switch (S)-region core repeats (ovals) precede each set of constant region (CH) exons.
(B and C) A conserved transcription unit comprising a non-coding intervening (I)-exon, an intronic S-region and a downstream set of CH exons is expanded for m
(B) and a (C) regions. CH12 cells transduced with shCtrl or shDDX1 were analyzed by DIP with the S9.6 RNA:DNA hybrid-specific antibody (IP) or no antibody
control (–), after 24 hr in UNS- or CIT-stimulated conditions. Probes employed (1–13) are indicated. Values were normalized both to probe 2 in each sample and
probe 9 in shCtrl CIT cells in each experiment (n = 5, mean ± SD). Dashed line represents background signal (DIP levels for probe 2 in shCtrl UNS cells). See also
Figure S3.depleted from CH12 cells using short-interfering RNA (siRNA),
confirming that reduced R-loop levels is a direct effect of
DDX1 depletion (Figures S3A–S3C). Validation of our DIP
approach and the specificity of the S9.6 antibody was shown
by loss of RNA:DNA hybrid signals upon treatment with recom-
binant RNaseH (Figures S3D and S3E). We conclude that
DDX1 depletion results in reduced levels of R-loops over IgH
S-regions once cells have been induced to undergo CSR.
DDX1 Binds to G4 Structures in Intronic Switch RNAs
A notable feature of S-regions is that they are particularly en-
riched with clusters of guanines nucleotides (G-clusters) gener-
ally present among AID target motifs. Once transcribed as
GLT, intronic G-clusters form G4 structures that have been
shown to bind AID and somehow target it to S-region DNA
(Zheng et al., 2015). We therefore tested the role of DDX1 in
theG4RNA-guidedmechanism of CSR.We used biotinylated ol-
igonucleotides containing four Sm repeats in tandem (Sm4G) in
RNA pull-down assays (Figure 4A). Mutated Sm4G lacking gua-
nine clusters (Sm4Gmut) cannot form G4 and was used as a654 Molecular Cell 70, 650–662, May 17, 2018negative control. We confirmed that Sm4G forms G4 when stabi-
lized by potassium (Sm4G-K+) but not lithium (Sm4G-Li+) cations,
as shown by a higher molecular weight smear observed for
Sm4G-K+ samples following gel fractionation (Figure S4A).
Also, circular dichroism spectroscopy showed a characteristic
absorbance spectrum for parallel G4 structures in Sm4G-K+,
but not Sm4G-Li+, samples (positive peak at260 nm and nega-
tive peak at 240 nm, Figure S4B). We next mixed pre-folded
RNA oligonucleotides with whole-cell extracts from CH12 cells
stably expressing tagged AID (AIDFLAG-HA). As expected, AID
was selectively pulled down with Sm4G-K+ (Zheng et al., 2015).
Notably, DDX1 was also pulled down using Sm4G-K+ but not
Sm4G-Li+ or Sm4Gmut oligonucleotides (Figure 4B). We then
evaluated whether DDX1 binding was dependent on AID
expression, as DDX1 has been shown to interact with chro-
matin-bound AID (Willmann et al., 2012). Extracts from AID-defi-
cient CH12 cells obtained by CRISPR/Cas9-mediated gene
inactivation (AID KO, Figures S4C–S4E) were used in the
same pull-down experiment. Notably, DDX1 was still pulled
down with Sm4G-K+ oligonucleotides (Figure 4C) suggesting
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Figure 4. DDX1 Binds to G4 Structures in Intronic Switch RNAs
(A) RNA oligonucleotides consisting of 4 tandem Sm repeats (Sm4G) or a G-to-C mutant (Sm4Gmut).
(B and C) RNA pull-down assays with protein extracts from (B) AIDFLAG-HA or (C) AID KO CH12 cells, CIT stimulated for 48 hr. Western blots were analyzed for
DDX1 and AID (FLAG tag) and RNA recovered from beads measured by dot blot. Representative results from at least 3 independent pull-downs.
(D) Native electrophoretic mobility shift assays (EMSA) with 32P-labeled Sm4G and Sm4Gmut RNA oligonucleotides and rDDX1 (WT) or rDDX1-K52A (ATPase
mutant) proteins (1, 2, or 4 mg). Representative results from at least 3 independent assays.
(E–H) CH12 cells were transfected with a pcDNA3 vector expressing GFP or N-terminal GFP-tagged human DDX1-K52A cDNA (GFP::DDX1-K52A), and cultured
in UNS or CIT-stimulated conditions.
(E) Percentage of GFP+ cells 24 hr and 40 hr after transfection measured by flow cytometry (n = 4, mean ± SD).
(F) Western blot of GFP+, fluorescence-activated cell sorted cells for DDX1 and Tubulin loading control (24 hr after transfection, 2 replicates).
(G) Quantification of CSR in GFP– and GFP+-gated cell populations (40 hr after transfection; n = 4, mean ± SD).
(H) DIP analyses with S9.6 antibody (IP) or no antibody control (–), 24 hr after transfection in CIT-stimulated conditions using Sa region probe 9.
Values were normalized to probe 2 in each sample and probe 9 in shCtrl CIT cells in each experiment (n = 3, mean ± SD). See also Figure S4.AID-independent interaction of DDX1 with G4 RNA. A RNA dot-
blot assay confirmed that RNA amounts recovered from strepta-
vidin beads in different conditions were equivalent (Figures 4B
and 4C, bottom). We conclude that DDX1 specifically binds to
Sm4G RNA containing G4 structures independently of AID.
We next performed native electrophoretic mobility shift assays
(EMSAs) to show that recombinant human DDX1 (rDDX1) pro-
teins (Kellner et al., 2015) directly bind 32P-labeled Sm4G RNA ol-
igonucleotides. RNA:protein complexes were readily detectable
with increasing concentrations of rDDX1, as two major high-mo-
lecular-weight bands (Figure 4D). These two distinct complexes
may reflect different conformations of the Sm4G RNA or DDX1dimer formation. Of note, binding of rDDX1 to Sm4Gmut RNA
was completely abolished (Figure 4D). A mutant version of
rDDX1, where the conserved lysine residue in the Walker A
motif I was mutated to alanine (rDDX1-K52A) (Kellner et al.,
2015) was also tested. The Walker A motif is part of the ATP-
binding site in DEAD-box helicases and is found in many
NTPases (Pause and Sonenberg, 1992). Interestingly, rDDX1-
K52A showed enhanced binding to Sm4G RNA as compared to
rDDX1 (Figure 4D). We confirmed rDDX1 and rDDX1-K52A
bind specifically to G4 RNA and not G4 DNA (Figure S4F) or
ssDNA (Figure S4G). Limiting amounts of rDDX1 proteins and ol-
igonucleotides that form tetramolecular G4 substrates wereMolecular Cell 70, 650–662, May 17, 2018 655
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Figure 5. DDX1 and G4 RNA-Dependent R-Loops in IgH S-Regions
(A and B) CH12 cells transduced with shCtrl or shDDX1 were analyzed by DIP with S9.6 antibody (IP) or no antibody control (–). Cells were cultured in CIT-
stimulated conditions with DMSO (Control), the G4 stabilizer pyridostatin (PDS, 10 mM), the G4 RNA-specific derivative carboxypyridostatin (cPDS, 10–40 mM) or
the splicing inhibitor Pladienolide B (PlaB, 1 mM) for 4 hr. DIP signals shown for upstream Sm region (probe 4) (A) and Sa region (probe 10) (B). Values were
normalized to shCtrl DMSO (nR 3, mean ± SD).
(C–E) In vitro RNA:DNA hybrid assay using 32P-labeled tetramolecular G4 RNA and complementary DNA strands. Reactions were performed with 1 mg WT or an
ATPase mutant (K52A) of rDDX1 at 25C for 10 min (C and D) or 10, 20, and 30 min (E). (D) RNaseH treatment of RNA:DNA hybrids. Data shown in (C) and (D) are
representative of at least 3 independent assays. See also Figure S5.used to compare protein binding affinity to G4 RNA and G4 DNA
structures. As before, mutant rDDX1-K52A showed enhanced
binding to G4 RNA compared to rDDX1 and a gel shift band of
a higher molecular weight, which may reflect multiple rDDX1-
K52A molecules binding to one or more G4 RNA. Notably, no
G4 DNA interaction with either WT or mutant rDDX1 was detec-
tible. Our observations reveal that DDX1 directly binds to G4
RNA and that an ATPase-deficient mutant forms a more stable
complex, indicative of reduced substrate turnover.
The above findings prompted us to investigate whether DDX1-
K52A functions as a dominant-negative mutant when introduced
into CH12 cells. Following transient transfection of N-terminal
GFP-tagged human DDX1-K52A cDNA into CH12 cells, we
observed a strong selection against cells expressing DDX1-
K52A (Figure 4E). Furthermore, GFP+ cells expressed only low
levels of mutant DDX1 when compared to endogenous DDX1
protein levels (Figure 4F). Despite this, DDX1-K52A-expressing
cells showed significantly reduced CSR toward IgA upon CIT
stimulation (Figure 4G). The levels of IgA+ cells in CIT cultures
was approximately half of that of cells expressing GFP only
or untransfected cells (GFP–). Interestingly, we also detected
reduced R-loop levels upstream of the Sa region in CIT-stimu-
lated cells expressing DDX1-K52Awhen comparedwith cells ex-
pressing only GFP (Figure 4H). These results show that a DDX1656 Molecular Cell 70, 650–662, May 17, 2018mutant deficient for ATP hydrolysis can compete effectively
with an excess of WT DDX1 to reduce CSR. It is possible that
DDX1-K52A sequesters G4 RNA away from WT DDX1. This will
in turn impair the formation of RNA:DNA hybrids over IgH S-re-
gions and so diminish efficient CSR.
DDX1 Modulates G4 and R-Loop Structures
We next aimed to connect our DDX1 and G4 RNA interaction
data (Figures 4B–4D) with diminished R-loop levels over IgH
S-region in DDX1-depleted cells (Figure 3). To do this, we em-
ployed pyridostatin (PDS), a generic G4-interacting small mole-
cule. PDS has been show to bind and stabilize G4 structures
at telomeres and other regions of the human genome where it
induces DNA damage and cell-cycle arrest (Rodriguez et al.,
2012). We therefore treated shCtrl and shDDX1 CH12 cells
with PDS for a 4-hr period, which did not affect cell division (Fig-
ure S5A). DIP analysis confirmed that similar levels of R-loops
were detected after 4 or 24 hr of CIT stimulation (Figure S5B).
Interestingly, we observed a 2-fold decrease in R-loop levels up-
stream Sm and Sa regions in PDS-treated shCtrl cells when
compared with DMSO controls (Figures 5A and 5B). To rule
out the possibility that decreased R-loop levels in PDS-treated
cells is due to stabilization of G4 structures on the non-template
DNA stand of S-regions (Dempsey et al., 1999; Duquette
et al., 2004), we employed the G4 RNA-specific derivative
carboxyPDS (cPDS) (Di Antonio et al., 2012). As with PDS, we
observed a 2-fold decrease in R-loop levels upstream Sm and
Sa regions in cPDS-treated shCtrl cells (Figures 5A and 5B). In
contrast, when DDX1 was depleted similar R-loop levels were
detected between DMSO and PDS or cPDS conditions. These
results suggest that G4 RNA stabilization reduces R-loops over
IgH S-regions in effect antagonizing DDX1.
Next, we evaluated whether limiting the production of G4
RNA decreased R-loop levels over IgH S-regions. ShCtrl and
shDDX1 CH12 cells were treated with the spliceosome inhibitor
Pladienolide B (PlaB) as G4 RNA has been shown to derive
from switch RNA introns (Zheng et al., 2015). When cells
were treated with PlaB and CIT stimulation for 4 hr, we
observed 50% lower levels of R-loops upstream Sm and Sa re-
gions in shCtrl cells as compared to DMSO controls (Figures 5A
and 5B). Notably, this PlaB effect was not evident in DDX1-
depleted cells. The possibility that splicing inhibition decreases
R-loop levels per se and is not due to decreased accumulation
of intronic G4 RNA was tested by treating cells with PlaB only
after 20 hr of CIT stimulation (Figure S5C). In this case, a similar
abundance of Sm-region R-loops was observed in both
PlaB-treated and DMSO control cells. Sa-region R-loops
were however slightly decreased under these conditions. As a
control, transcription elongation was inhibited using Actino-
mycin D (ActD) or 5,6-Dichloro-1-b-D-ribofuranosylbenzimida-
zole (DRB) after 20 hr of CIT stimulation. A marked decrease
in S-region R-loop levels in shCtrl and shDDX1 CH12 cells
was observed (Figure S5D). We used qPCR to confirm
increased levels of unspliced GLT in the presence of PlaB
and a robust inhibition of m and a GLTs with both ActD and
DRB (Figure S5E). We conclude that when the accumulation
of intronic switch RNA is prevented from the onset of CIT stim-
ulation, the levels of R-loops over IgH S-regions are decreased
by half even in the presence of DDX1.
To directly test whether DDX1 can convert G4 RNA into
RNA:DNA hybrids, in vitro assays were carried out using
32P-labeled tetramolecular G4 RNA and complementary DNA
strands. Higher-order G4 RNA:protein complexes were de-
tected in the presence of WT or K52A mutant rDDX1 protein,
confirming DDX1 binding to G4 RNA structures (Figure 5C).
Notably, a distinct band was also detected when both
rDDX1 and complementary DNA strands were used (Fig-
ure 5C). To confirm that this band is a RNA:DNA hybrid, we
verified its sensitivity to RNaseH treatment (Figure 5D). Impor-
tantly, the intensity of the RNA:DNA hybrid signal was dimin-
ished when the rDDX1-K52A mutant was used even when
the reaction was allowed to proceed for longer periods of
time (Figure 5E). These in vitro experiments demonstrate
that rDDX1 acts on G4 RNA structures to convert them into
RNA:DNA hybrids. Taken together, we predict that DDX1
acts to promote the conversion of switch G4 RNA into S-re-
gion R-loops at the IgH locus.
AID Binding to IgH S-Regions Is Dependent on DDX1
The ability of DDX1 to bind G4 RNA prompted us to investigate
whether impaired CSR in DDX1-depleted cells is due to reduced
AID binding to S-region DNA. We observed a significant reduc-tion of AID occupancy upstream Sm and Sa regions in DDX1-
depleted cells by chromatin immunoprecipitation (ChIP) (Figures
6A and 6B), even though we detected near equal amounts of AID
in whole-cell and nuclear extracts in shCtrl and shDDX1 CH12
cells (Figure 6C). To clearly distinguish AID-specific signal from
background levels, we determined ChIP signals in AID KO
CH12 cells (Figures 6A and 6B). Strikingly, AID binding to IgH
S-regions in DDX1-depleted cells was reduced to background
levels. Because AID is a DNAmutator enzyme, it has low nuclear
abundance compared to the cytoplasm, as observed by immu-
nofluorescence (IF) staining (Figure S6A). Although nuclear AID
IF signals were slightly reduced in DDX1-depleted cells (Fig-
ure S6B), this small difference could not account for the strong
decrease on AID occupancy at IgH S-regions (Figures 6B and
6C). Similarly, co-immunoprecipitation experiments showed
that only a small proportion of nuclear AID (less than 5%) directly
interacts with DDX1 (Figures 6D and 6E), possibly the fraction
that is chromatin bound (Willmann et al., 2012). Thus, it is unlikely
that DDX1 recruits AID through direct protein-protein interac-
tions. Instead, we predict that, in B cells undergoing CSR,
DDX1 is required for efficient AID targeting to S-regions via
switchG4RNA. In effect, DDX1may act to increase AID retention
on the non-template DNA strand by promoting R-loop formation
over S-regions.
Next, we determined the effect of DDX1 depletion on Sm mu-
tation frequency and nucleotide specificity in DNA sequences
from Sm-Sa recombination products in CH12 cells. Overall
decreased levels of Sm mutation were detected after DDX1
knockdown (Figure 6F and Figure S7A), specifically at G/C
base pairs (Figure 6G), which is consistent with diminished AID
occupancy. To further extend this analysis, we mapped recom-
bination breakpoints across both Sm and Sa regions in 100-bp
bins relative to PCR primer positions (Figure S7B). We observed
a clear overrepresentation of Sm recombination sites within bin F,
particularly in shDDX1 cells. Detailed analysis of these Sm break-
points in shCtrl cells revealed a strong preference for recombina-
tion with Sa sequences within bin L (Figure S7B) and a charac-
teristic 9- to 10-nt length of complementary nucleotides or
microhomology (MH) at the Sm-Sa breakpoint (Table S2). In
contrast, for shDDX1 cells around half of the Sm breakpoints
within the bin F were recombined to Sa sequences within bin R
(Figure S7B) and showed 1 nucleotide length of Sm-SaMH (Table
S3). The length of MH regions present at S-S junctions reflects
the end-joining processes that ligate DSBs. CSR primarily de-
pends on canonical non-homologous end joining (NHEJ) mech-
anisms for DSB repair but sometimes cells employ an alternative
NHEJ repair pathway characterized by larger stretches of MH
present at S-S junctions (Boboila et al., 2012). Therefore, we
analyzed the length of MH regions at all Sm-Sa recombination
products. The majority of Sm-Sa junctions in shCtrl CH12 cells
share between 0 and 4 nt of MH between donor and acceptor
sequences (Figure S7C). However, a considerable proportion
of Sm-Sa junctions revealed more than 4 nt of MH, reflective of
alternative NHEJ mechanisms. This pattern was also observed
in DDX1 knockdown cells, although there was a significant in-
crease in the percentage of Sm-Sa junctions with a single-nucle-
otide homology (Figure S7C). We conclude that the skewed dis-
tribution of Sm-Sa recombination breakpoints in DDX1-depletedMolecular Cell 70, 650–662, May 17, 2018 657
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Figure 6. Reduced AID Binding to IgH S-Regions in DDX1-Depleted Cells
CH12 cells transduced with shCtrl or shDDX1 were cultured in CIT-stimulated conditions and analyzed after 24 hr.
(A and B) AID ChIP analysis in m (A) and a (B) regions. Values shown for antibody (IP) or IgG control are expressed as percentage of Input (n = 3, mean ± SD). AID
KO CH12 cells were used to determine background levels (dashed line represents probe 2 signal).
(C) Western blot of whole-cell and nuclear protein extracts for DDX1 and AID. Purity of nuclear extracts is shown by absence of cytoplasmic Tubulin, and CTCF
levels were used as loading control. Amount of nuclear extract loaded is 15 times increased compared to the equivalent amount of whole cell extracts (WCEs).
Data are representative of 3 independent experiments.
(D and E) Co-immunoprecipitation assays with anti-DDX1 antibody and nuclear protein extracts from (D) AIDFLAG-HA or (E) WT CH12 cells CIT stimulated for 24 hr.
Western blots were analyzed for DDX1, AID (or FLAG tag), and the tRNA ligase subunit RTCB as a positive control. Representative results from 2 independent pull-
downs on each cell type.
(F) Frequency of Sm mutations (shCtrl normalized; n = 4, mean ± SD). Number of mutations per total number of bp analyzed and percentage of mutation in
recombined Sm DNA sequences in each experiment are shown in Figure S7A.
(G) Number of Smmutations at each nucleotide, expressed per 103 bp (n = 4). Unique Sm-Sa sequences were amplified from genomic DNA extracted from shCtrl
(50 sequences) or shDDX1 (62 sequences) CH12 cells cultured in CIT conditions for 72 hr.
See also Figures S6 and S7.cells underlies the prevalence of Sm-Sa junctions with a single-
nucleotide homology. However, in the context of CSR both
canonical and MH-mediated NHEJ mechanisms still operate
upon DDX1 depletion.658 Molecular Cell 70, 650–662, May 17, 2018DISCUSSION
We identify DDX1 as a DEAD-box RNA helicase required for CSR
at the IgH locus.Weprovide evidence that DDX1 directly binds to
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Figure 7. Model for DDX1 Role in CSR
(A) RNA polymerase II (Pol II) makes switch transcripts, which are spliced to
release the G4 containing intron. Intron lariat intermediates are debranched by
the DBR1 enzyme as previously shown (Zheng et al., 2015). This converts the
intron lariat into its linear form prior to folding into G4 RNA structures. Pre-
sumably, switch transcripts are trimmed by 50 and 30 exonucleases. G4 RNA
and AID are then targeted to the S-region DNA through the action of the RNA
helicase DDX1 that promotes the formation of R-loops. Hypothetically, hybrid
G4 RNA:DNA structures could also occur in the non-template DNA strand
(Pucella and Chaudhuri, 2017).
(B) R-loops form behind elongating Pol II in S-region and recruit AID to the
single-strand DNA.G4 structures present within intronic switch RNA and by so doing
targets AID to S-region DNA to promote CSR. We suggest that
switch G4 RNA is modulated by DDX1-dependent mechanisms
leading to R-loop formation over IgH S-regions (Figure 7). This
post-transcriptional mechanism of R-loop formation contrasts
with the view that that R-loops exclusively form co-transcription-
ally when RNA exits RNA polymerase II during transcription and
anneals with the template DNA strand (Roy et al., 2008). The
presence of G-clusters has been described as a key determinant
of co-transcriptional R-loop formation as these clusters may act
to nucleate thread-back of RNA into the DNA duplex behind the
elongating polymerase (Roy and Lieber, 2009; Zhang et al.,
2014). We propose that post-transcriptional R-loop formation
also relies on the presence of G-clusters in intronic switch RNA
to form G4 structures that are recognized by DDX1 and target
AID to IgH S-regions through RNA:DNA base-pairing. Previous
studies have reported that limiting the generation of switch
RNA introns by shRNA-mediated knockdown of the lariat de-
branching enzyme DBR1 had no detectable effect on R-loop
levels (Zheng et al., 2015). Possibly sufficient G4 RNA remainedin these DBR1-depleted cells to still allow full R-loop formation.
We predict that both co-transcriptional and post-transcriptional
mechanisms may cooperate to allow efficient CSR (Figure 7).
Recent studies have demonstrated that G4 RNAs are globally
unfolded in eukaryotic cells, presumably due to their deleterious
effects on gene expression (Guo and Bartel, 2016). These find-
ings have led to the suggestion that G4 RNAs are under tight
regulation and are restricted to particular cell types or stages.
We anticipated that B cells induced to undergo CSR provide a
clear example of such regulation as a specific mechanism to
target AID to the IgH locus (Zheng et al., 2015). Previously,
only the DEAD/DEAH-box family RNA helicases DHX36, DHX9,
and DDX21 have been shown to act on G4 RNA in vitro (Chakra-
borty and Grosse, 2011; Creacy et al., 2008; McRae et al., 2017).
Our findings now demonstrate a physiological role for DDX1 in
B cells undergoing CSR as part of the molecular machinery
that modulates switch G4 RNA and R-loop structures. Impor-
tantly, we demonstrate that DDX1 cKOmice have reduced levels
of switched Ig both at steady state and following immunization.
While it is possible that DDX1 is involved in other aspects of
B cell activation that can affect antibody responses, these data
constitute definitive evidence for a role for G4 RNA in CSR
physiology.
Recent studies show that AID deaminates ssDNA more
robustly in the context of structured substrates, such as G4 or
branched structures (Qiao et al., 2017). Interestingly, AID recog-
nition occurs on single-stranded overhangs, either of DNA or
RNA nature. In this context, G4 RNA-dependent targeting of
AID to S-regions could rely on the DDX1-mediated formation of
hybrid RNA:DNA structures, perhaps in the form of combined
G4 and R-loops (Figure 7). However, whether such G4-R-loop
structures are present at the IgH locus remains to be experimen-
tally tested (Pucella and Chaudhuri, 2017). G4 DNA structures
have been previously reported to be present on the non-tem-
plate DNA strand of Sm and Sg regions in vitro (Dempsey et al.,
1999; Duquette et al., 2004). However, other studies failed to
detect such G4 DNA structures in Sg3 and Sg2b regions in
LPS-stimulated B cells (Yu et al., 2003). It would be important
to evaluate the exact nature of G4 structures present in vivo at
the IgH locus, as a G4 RNA-mediated AID targeting mechanism
may also occur at non-Ig loci (Zheng et al., 2015). So far, only
anti-sense (Pefanis et al., 2014) and convergent transcription at
super-enhancers (Meng et al., 2014; Qian et al., 2014; Wang
et al., 2014) have been shown to be involved in inappropriate tar-
geting of AID at non-Ig hotspots by providing ssDNA substrates.
Many DEAD-box family members can only catalyze the un-
winding of short dsRNA (%14 bp) by local strand separation, a
process reduced by increased substrate stability (GC content)
(Rogers et al., 2001). Interestingly, DHX36 has been suggested
to resolve G4 RNA structures by a similar mechanism employed
by DEAD-box helicases on dsRNA (Chen et al., 2015). Possibly
the partial unwinding of switch G4 RNA by DDX1 is facilitated
by simultaneous base-pairing of unfolded RNA to S-region
DNA in a R-loop structure. In this context, exosome activity
could expose the template DNA strand for RNA annealing
(Basu et al., 2011). Alternatively, anti-sense transcription at
S-regions could also render the template DNA strand free to
base pair with switch RNA (Perlot et al., 2008). Also, exposedMolecular Cell 70, 650–662, May 17, 2018 659
stretches of ssDNA have been proposed to occur in S-regions as
a result of R-loop collapse following RNaseH action or negative
supercoiling behind transcribing RNA polymerase II (Parsa et al.,
2012; Yu et al., 2003).
DDX1-mediated R-loop formation downstreamof G4RNAmay
also be coordinated through interaction of DDX1 with other pro-
tein factors. Previous studies have demonstrated that DDX1 has
higher affinity for ADP then ATP, which might cause the protein
to be predominantly found in a dead-end ADP-bound form at
cellular nucleotide concentrations (Kellner et al., 2015). It has
been suggested that DDX1 recycling relies on interactions with
otherproteins through its uniqueSPRYdomain, known to function
as a protein-protein interaction platform (Kellner and Meinhart,
2015; Kellner et al., 2015). Thismay explainwhy our in vitro results
show only partial DDX1-dependent conversion of G4 RNA into
RNA:DNA hybrids. In a cellular context DDX1 is part of different
multimeric protein complexes, such as tRNA ligase (Popow
et al., 2014), the Drosha microprocessor (Han et al., 2014), and
the dsRNA sensor DDX1-DDX21-DHX36 complex (Zhang et al.,
2011). The tRNA ligase has been previously implicated in the con-
trol of antibody secretion in plasma cells, where it mediates un-
conventional splicing of the mRNA encoding for the transcription
factor XBP1 as part of the unfolded protein response (Jurkin et al.,
2014). It will be interesting to determinewhich interacting proteins
are functionally linked to the role of DDX1 in CSR.
DDX1 has been associated with cellular events downstream
of DNA damage and its phosphorylation by ATM precedes
recruitment to sites of DSBs containing RNA:DNA structures
(Li et al., 2008). In this context, DDX1 may be required to clear
RNA from DSBs located within transcription units. This may
preserve end-resected DNA in a single-strand conformation
and so enable homology-directed DSB repair (Li et al., 2016).
In DDX1-depleted cells, we detected a skewed distribution of
recombination breakpoints in IgH S-regions, also reflected in
the length of MH at S-S junctions. While these effects might be
a direct consequence of defective AID targeting, the role of
DDX1 in homology-directed DSB repair may also relate to IgH
recombination. A recent study proposed that R-loops have
important roles downstream of AID targeting, by contributing
to replication origin specification that promotes DSB resolution
in CSR (Wiedemann et al., 2016). Future experiments are
required to establish whether DDX1 has a role on CSR steps
downstream of AID targeting, such as in the resolution of DSBs.
In summary, we reveal the DEAD-box RNA helicase DDX1 as a
molecular player in the post-transcriptional, RNA-guided mech-
anisms of AID targeting during CSR. Furthermore, we uncover a
previously unanticipated role for DDX1-dependent G4 RNA re-
modeling in the regulation of R-loop levels over IgH S-regions.
These findings may well extrapolate to other molecular functions
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell lines
CH12 cells (Nakamura et al., 1996) were grown in RPMI-1640 culture medium containing 10% heat-inactivated fetal bovine serum
(FBS, GIBCO), 100 U/mL of penicillin, 0.1 mg/mL of streptomycin (GIBCO), 5% NCTC-109 medium (Sigma-Aldrich), and 10 mM
b-mercaptoethanol at 37C in a 5% CO2 atmosphere. For CH12-AID
FLAG-HA (Jeevan-Raj et al., 2011) and shRNA-expressing
CH12 cell lines the medium was further supplemented with puromycin (2 mg/mL; Sigma-Aldrich).
Mice
Mice with the conditional C57BL/6N-Ddx1tm1a(EUCOMM)Hmgu/Cnrm allele (obtained from Infrafrontier, European Mouse Mutant Archive
(EMMA)) were crossed with FLPeR mice (obtained from the Jackson Laboratory) to generate the DDX1loxP allele. Both DDX1loxP/loxP
and Aicda-Cre (Kwon et al., 2008) mice were maintained on the C57BL/6J genetic background and genotyping was performed by
PCR (see Table S4 for primer sequences). The WT DDX1 allele was identified as a 777-bp and the DDX1loxP allele as a 919-bp
PCR fragment. Mice were kept at specified pathogen free conditions and littermates of the same sex were randomly assigned to
experimental groups. All animal experiments were performed in accordance with Home Office (UK) regulations and approved by
the University of Oxford Local Ethical Committee.
Primary B cell cultures
Naive B cells were isolated from spleens of 8-10 week old mice by magnetic depletion using the B cell isolation kit (Miltenyi
Biotech). For DDX1 deletion, purified B cells (> 95% CD19+ cells) were washed 3x with Opti-MEM (ThermoFischer) and cultured
at 10 3 106 cells/ml in Opti-MEM with 200 U TAT-Cre recombinase for 45 min at 37C. Subsequently, TAT-Cre was inactivated
by adding FBS at a final concentration of 10%, cells were washed once with RPMI-1640 culture medium and then cultured atMolecular Cell 70, 650–662.e1–e8, May 17, 2018 e3
37C in a 5% CO2 atmosphere. Cells were harvested 1 day after TAT-Cre addition for analysis of deleted DDX1 alleles on genomic
DNA, identified as a 380-bp PCR fragment (see Table S4 for primer sequences). DDX1 protein depletion was analyzed 4 days after
TAT-Cre treatment on total protein extracts by western blot.
METHOD DETAILS
Immunization
Mice (6-9 week old) were immunized subcutaneously in the flank with 100 mg endotoxin-depleted ovalbumin (EndoFit, Invivogen)
formulated in Complete Freund’s adjuvant (Sigma-Aldrich) as prime, and 4 weeks later as booster in Incomplete Freund’s adjuvant
(Sigma-Aldrich). Bloodwas taken every twoweeks and sera separated and frozen at80C.Micewere euthanized at week 2 or week
10 post-immunization and spleens were harvested for further analyses.
ELISA and Multiplex Immunoassay
Serum Ig concentrations in naive (8-12 week old) and immunized mice were measured using a Procarta Multiplex Immunoassay
(ThermoFischer) according to manufacturer’s instructions. Ovalbumin-specific IgG and IgM responses in immunized mice were
measured by ELISA in SpectraPlate-96 HB plates (PerkinElmer). Ovalbumin-specific IgG levels were determined using 10 mg/mL
ovalbumin (grade V, Sigma-Aldrich) in 0.1M NaHCO3 buffer pH 8.5 to coat plates at 4
C overnight. After blocking with 1% BSA in
PBS, serum serial dilutions were incubated at room temperature for 2 hr. HRP-labeled anti-mouse IgG (Bethyl) antibody was
used for detection. For ovalbumin-specific IgM detection, serum serial dilutions were incubated on plates coated with 1 mg/mL
anti-mouse IgM capture antibody (BD Biosciences) in PBS. Subsequently, 10 mg/mL biotinylated ovalbumin was added and incu-
bated at 4C overnight followed by HRP-labeled anti-mouse IgM antibody detection. HRP activity was developed following addition
of 1-Step Ultra TMB-ELISA Substrate Solution (ThermoFischer) according tomanufacturer’s instructions. Endpoint titers were calcu-
lated as a measurement of relative concentration using a cutoff of 2x the mean of a negative control reading (naive serum).
In vitro antigen recall responses in splenocytes
Splenocytes were plated at 0.5 3 106 cells/200 mL in RPMI-1640 culture medium in the presence of 50 mg/mL ovalbumin (EndoFit,
Invivogen). After 3 days, IFNg concentration in the culture supernatant was calculated using ELISA (ThermoFischer) according to
manufacturer’s instructions.
CSR induction and chemical treatments
Primary B cells were activated at a density of 0.83 106 cells/mL in the presence of 25 mg/ml lipopolysaccharide from Escherichia coli
O55:B5 (LPS, Sigma-Aldrich) or LPS plus 10 ng/mL recombinant murine IL-4 (Peprotech) for 3-4 days, to induce proliferation and
CSR to IgG3 and IgG1, respectively. To induce CSR to IgA, CH12 cells were cultured at a density of 0.023 106 cells/mL in the pres-
ence of 1 mg/mL purified anti-mouse/rat CD40 (HM40-3, eBioscience), 10 ng/mL recombinant murine IL-4 (Peprotech) and 2 ng/mL
recombinant human TGF-b1 (R&D Systems) (CIT) for 3 days. Cells were cultured at a density of 0.13 106 cells per mL for analysis at
24 hr or 4 hr after CIT stimulation and treated at a final concentration of 10 mM pyridostatin (PDS, Sigma-Aldrich), 10-40 mM carbox-
ypyridostatin (cPDS, (Di Antonio et al., 2012)), 1 mM pladienolide B (PlaB, Santa Cruz) (Kotake et al., 2007), 5 mg/mL actinomycin D
(ActD, Sigma-Aldrich) or 150 mM 5,6-dichloro-1-b-D-ribofuranosylbenzimidazole (DRB, Sigma-Aldrich) for 4 hr using DMSO as
vehicle.
Flow Cytometry analyses
CSRwas evaluated by cell surface staining with purified anti-mouseCD16/CD32 (BDBiosciences), FITC-conjugated anti-mouse IgM
(eBiosciences), biotin-conjugated anti-mouse IgA (eBiosciences), biotin-conjugated anti-mouse IgG3 (BD Biosciences), biotin-con-
jugated anti-mouse IgG1 (BD Biosciences), PE-conjugated anti-mouse CD19 (eBiosciences) and APC-conjugated Streptavidin
(eBiosciences) in FACS buffer (PBS, 0.5% BSA and 2mM EDTA). Splenic cell suspensions were stained after red-blood cell lysis us-
ing purified anti-mouse CD16/CD32 (BDBiosciences), Alexa Fluor 488-conjugated anti-human/mouse GL-7 (eBiosciences), PE-con-
jugated anti-mouse CD95 (BD Biosciences), PCP-Cy5.5-conjugated anti-mouse CD19 (eBiosciences), biotin-conjugated peanut
agglutinin (PNA) and APC-conjugated Streptavidin (eBiosciences) in FACS buffer. Dead cell exclusion was carried out by staining
with 7-AAD or DAPI. For intracellular detection of m heavy-chains, cells were stained on the cell surface with purified anti-mouse
CD16/CD32 (BD Biosciences), PCP-Cy5.5-conjugated anti-mouse CD19 (eBiosciences), APC-conjugated anti-mouse B220
(eBiosciences) and PE-conjugated anti-mouse CD138 (Biolegend) and subsequently washed in PBS and fixed in PBS, 2%PFA. After
permeabilization in 0.5% Saponin in FACS buffer, cells were stained with Alexa Fluor 488-conjugated anti-mouse m heavy-chain
(ThermoFischer). Samples were acquired on a FACSCalibur or LSRFortessa X-20 flow cytometer (BD Biosciences) and analyzed
with FlowJo software (Tree Star).
Cell proliferation and cell cycle analyses
For analysis of cell proliferation, 10x106 cells were stained with 2.5 mM carboxyfluorescein succinimidyl ester (CFSE, Biolegend) in
2 mL staining buffer (0.1% BSA in PBS at 37C) for 10 min at room temperature. The reaction was stopped by adding cells to 40 mLe4 Molecular Cell 70, 650–662.e1–e8, May 17, 2018
ice-cold RPMI-1640 culture medium. Cells were washed twice and cultured for 3 days before FACS analysis. Cell cycle profiles were
obtained by adding 10 mM of 5-bromo-20-deoxyuridine (BrdU, Sigma-Aldrich) to 0.5-1x106 CH12 cells 1 hr before harvesting. Cells
were washed in PBS, fixed in ice-cold 70% ethanol and kept overnight at 4C. For BrdU staining, cells were incubated in 2N HCl,
0.5% Triton X-100 for 30 min at room temperature followed by a 2 min incubation in 0.1 M sodium tetraborate buffer, pH 8.0. Cells
werewashed in PBS, 1%BSA and incubatedwith 2 mL FITC-conjugated anti-BrdU antibody (BioLegend) diluted in PBS, 1%BSA and
0.5% Tween-20 for 1 hr at room temperature. Cells were washed once and stained with 0.02 mg/mL propidium iodide (PI) in PBS,
0.1% Triton X-100, 0.2 mg/mL RNase A for 30 min at room temperature before FACS analysis.
Lentiviral transduction of shRNA constructs and siRNA transfection
Stable expression of control shRNA (shCtrl, SHC002 Sigma-Aldrich) or DDX1-specific shRNAwas obtained by lentiviral transduction
of CH12 cells using the pLKO.1-puro system (SHC001 Sigma-Aldrich). Viral supernatants were produced in 293T cells (10 cm plates
in DMEM supplemented with 10% heat-inactivated FBS) transfected with 9 mg psPAX2 packaging vector (Addgene), 3 mg pMD2.G
envelope vector (Addgene) and 12 mg pLKO.1-puro shRNA vector using Lipofectamine 2000 according to manufacturer’s instruc-
tions (ThermoFischer). Medium was replaced to complete RPMI-1640 24 hr after transfection to begin viral production. Viral super-
natant was collected 48-72 hr after transfection andmixed with polybrene (8 mg/mL; Sigma-Aldrich). CH12 cells were resuspended in
viral supernatants at a density of 0.23 106 cells permL and selected in puromycin (2 mg/mL; Sigma-Aldrich) 24 hr after infection for up
to 7 days. Individual clones were isolated by serial dilution assays in the presence of puromycin and grown as independent shCtrl and
shDDX1 CH12 cell lines. For transient depletion of DDX1, 30 pmol of short-interfering (siRNA) was electroporated into 3x106 CH12
cells using Amaxa Cell Line Nucleofector Kit R (Lonza). A pool of 4 siRNAs was used to target mouse DDX1 (SMARTpool: siGENOME
DDX1 siRNA, Dharmacon) as well as a control siRNA against Luciferase (Anti-Luc siRNA-1, Dharmacon).
CRISPR/Cas9-mediated targeted deletion
Guide RNA sequences were designed using an online tool (http://tools.genome-engineering.org). A single guide RNA oligonucleotide
targeting mouse DDX1 exon 5 was cloned into pSpCas9(BB)-2A-Puro (PX459) (Addgene). Gene blocks containing Aicda guide RNA
sequences were cloned using TOPO PCR cloning kit (ThermoFischer) and used in combination with hCas9_D10A mutant plasmid
(Addgene). Guide RNA/Cas9 expression vectors were electroporated into CH12 cells using Amaxa Cell Line Nucleofector Kit R
(Lonza) and cells were cloned using serial dilution assays 72 hr after transfection. Individual clones were screened for homozygous
deletion using PCR and the genomic sequence of candidate alleles obtained by Sanger sequencing. Gene deletion was confirmed at
the protein level by immunoblot.
Expression of DDX1 dominant-negative mutant
Human DDX1 cDNA was amplified from HEK cells (see Table S4 for primer sequences) and cloned in frame with an N-terminal eGFP
tag in the pcDNA3.1 vector (ThermoFischer). A mutant version of DDX1 where a conserved lysine residue in the Walker A motif I was
mutated to alanine (K52A) was generated with QuikChange Site-Directed Mutagenesis kit (Agilent Technologies). CH12 cells were
electroporated using Amaxa Cell Line Nucleofector Kit R (Lonza) and cultured at a density of 0.2 or 0.08 3 106 cells per mL for an-
alyses after 24 or 40 hr, respectively. GFP positive cells were FACS sorted using aMoFlo Astrios EQ (Beckman Coulter) before Immu-
noblot or DIP analyses.
Protein extracts and western blot analysis
Whole-cell extracts were prepared in RIPA lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% NP-40, 0.5% Na-deoxycholate,
0.1% SDS, 10% glycerol) supplemented with a cocktail of protease and phosphatase inhibitors (Pierce). Cells were resuspended in
250 mL lysis buffer (5x106 cells), incubated for 30 min on ice and centrifuged (17,000 g at 4C for 10 min). For nuclear protein extracts,
10x106 cells were resuspended in 500 mL cell lysis buffer (50 mM Tris-HCl, pH 8, 300 mM Sucrose, 4 mMMgAc, 12.5 mM KCl, 1 mM
DTT, 10 mM b-mercaptoethanol, 0.3% NP-40 and 1mM PMSF) and incubated 5 min on ice followed by centrifugation (500 g for
10 min at 4C). The nuclear pellet was resuspended in 250 mL buffer B (50 mM Tris-HCl pH 7.5, 25 mM KCl, 5 mM MgCl2 and
1 mM PMSF), overlaid in 250 mL buffer B containing 200 mM sucrose and centrifuged again to avoid cytoplasm carry over. High-
salt extraction of nuclear proteins was carried out on ice for 30 min in 150 mL buffer C (20 mM HEPES pH 7.9, 400 mM NaCl,
1 mM EDTA, 1 mM EGTA, 2 mM DTT and 1 mM PMSF) followed by centrifugation (17,000 g at 4C for 10 min). Protein concentration
wasmeasured using Bio-Rad Protein Assay. Typically, 10 mg of whole-cell and 20 mg of nuclear protein extracts were used for immu-
noblot with anti-DDX1 (NovusBiologicals or ProteinTech), anti-AID (Cell Signaling L7E7), anti-Tubulin (Sigma-Aldrich), anti-Actin
(Sigma-Aldrich), anti-CTCF (Millipore) or anti-Histone H3 (Abcam) and HRP-conjugated secondary antibodies in TBST, 5% milk
(Sigma-Aldrich). For immunoblot analysis of RNA pull-down or co-Immunoprecipitation assays the following antibodies were addi-
tionally used: anti-FLAG (ThermoScientific), anti-FLAG-HRP (Sigma) and anti- HSPC117/FAAP (RTCB) (Santa Cruz). Relative quan-
tification of protein bands was done using ImageJ.
Nuclear RNA fractionation
Nuclear RNA fractionation was performed as previously described (Dye et al., 2006). Briefly, 2.5x106 cells were resuspended in
500 mL of ice-cold RLB buffer (10 mM Tris-HCl, pH 7.5, 140 mM NaCl, 0.5% NP-40, 1.5 mM MgCl2) and lysed by adding an equalMolecular Cell 70, 650–662.e1–e8, May 17, 2018 e5
volume of RLB buffer with 24% (m/v) sucrose. Nuclei were isolated by centrifugation (900 g at 4C for 10 min) and resuspended in
120 mL of NUN1 buffer (20 mM Tri-HCl, pH 7.9, 75mM NaCl, 0.5 mM EDTA, 50%Glycerol, 0.125 mM PMSF, 1mM DTT), followed by
the addition of 1.2 mL NUN2 buffer (20 mMHEPES-NaOH pH 7.6, 7.5mMMgCl2, 0.2 mM EDTA, 300 mMNaCl, 1 M urea, 1%NP-40,
1 mMDTT). Nuclei were incubated on ice for 15min andmixed by vortexing for 5 s every 5min. Nucleoplasm and chromatin fractions
were separated by centrifugation (14,000 g at 4C for 10 min). The nucleoplasm fraction RNA was extracted with phenol-chloroform
pH 4.3 and ethanol precipitated. The precipitate was resuspended in 200 mL of TURBO DNase buffer plus 4 U TURBO DNase (Am-
bion), incubated for 30 min at 37C, then extracted with phenol-chloroform pH 4.3 and ethanol precipitated. Chromatin pellets were
resuspended in 200 mL high salt buffer (10 mM Tris-HCl, pH 7.5, 500 mMNaCl, 10 mMMgCl2) and treated with 4U TURBO Dnase for
20 min at 37C, followed by 200 mL Proteinase K/SDS mix (16 U Proteinase K (Roche), 2% SDS) for 20 min at 37C. The chromatin-
associated (chRNA) RNA was extracted with phenol-chloroform pH 4.3 and ethanol precipitated. The precipitate was twice resus-
pended in 200 mL of 1x TURBODNase buffer plus 4 U TURBODnase, incubated for 30 min at 37C, then extracted with phenol-chlo-
roform pH 4.3 and ethanol precipitated. RNA was resuspended in 50 mL nuclease-free water (Ambion).
Quantitative PCR and High-throughput Sequencing Library preparation
Total RNA, extracted using TRIzol (ThermoFischer), or nuclear RNA fractions (1 mg) were used for cDNA synthesis with random hex-
amers and Superscript III Reverse Transcriptase according to manufacturer’s instructions (ThermoFischer). cDNA was diluted 10x in
nuclease-free water (Ambion) before it was used for quantitative PCR analysis in a Rotor-Gene Q real-time PCR cycler (QIAGEN),
using SYBRGreenMasterMix (QIAGEN) and gene-specific primers (Table S4). Minus Superscript III Reverse Transcriptase reactions
were used as a control for contaminating DNA and relative gene expression levels were calculated using the DCt method. Before
high-throughput sequencing library preparation, 2.5 mg chRNAwas depleted for rRNA using the Ribo-Zero rRNARemoval kit accord-
ing to manufacturer’s instructions (Illumina). Libraries were prepared from 100 ng RNA using the NEBNext Ultra Directional RNA Li-
brary Prep kit and NEBnext Multiplex Oligos (Index Primers Set 2) for Illumina according to manufacturer’s instructions (NEB). High-
throughput sequencing was performed on a HiSeq 4000 sequencer (Illumina) with 75 bp paired-end reads.
DNA immunoprecipitation (DIP) analysis to measure R-loop levels
DIP was performed as previously described (Skourti-Stathaki et al., 2011). Without prior cross-linking, 2.5-3x106 cells were washed
twice in PBS and lysed in 500 mL cell lysis buffer (5mMPIPES pH 8.0, 85mMKCl, 0.5%NP-40, 0.5mMPMSF and complete protease
inhibitor cocktail (Roche)) for 10min on ice. Nuclei were isolated by centrifugation (900 g at 4C for 5min), resuspended in 400 mL ice-
cold nuclear lysis buffer (50mMTris-HCl pH 8.0, 1%SDS, 10mMEDTA, complete protease inhibitor cocktail) and incubated with 6 U
of proteinase K (Roche) at 55C for 3 hr. Genomic DNA was isolated, followed by sonication to 100-500 bp fragments in IP dilution
buffer (16.7 mM Tris-HCl pH 8.0, 0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 167 mM NaCl, 0.5 mM PMSF, complete protease
inhibitor cocktail) using a Bioruptor (Diagenode). DIP was carried out using the S9.6 antibody (Boguslawski et al., 1986) overnight at
4C followed by 2 hr with Protein A Dynabeads (ThermoFischer). Immunoprecipitated (IP), no antibody control (-) and input DNA sam-
ples were used as templates for quantitative PCR analysis in a Rotor-Gene Q real-time PCR cycler (QIAGEN), using SYBR Green
Master Mix (QIAGEN) and primers spanning the entire mouse IgH m and a regions (Table S4). DIP signals were validated by sensitivity
to 10 U of Rnase H (Roche) treatment for 2 hr at 37C prior to the immunoprecipitation step.
Chromatin immunoprecipitation (ChIP) analysis
ChIP was performed using similar procedures to DIP with some modifications. Briefly, 2.5-3x106 cells were cross-linked with 1%
formaldehyde for 10 min at 37C, quenched with 0.125 M Glycine and washed twice in PBS before resuspension in nuclear lysis
buffer containing 0.5%SDS. Chromatin sonicated to 100-500 bp fragments was diluted in IP dilution buffer and pre-cleared with Pro-
tein G Dynabeads (ThermoFischer) for 1 hr at 4C. Pre-cleared supernatants were immunoprecipitated with anti-AID antibody
(Chaudhuri et al., 2003) or rabbit IgG overnight at 4C, followed by 2 hr with Protein G Dynabeads. Immunoprecipitated (IP), IgG con-
trol and input DNA samples were used as templates for quantitative PCR analysis in a Rotor-Gene Q real-time PCR cycler (QIAGEN),
using SYBR Green Master Mix (QIAGEN) and primers spanning the entire mouse IgH m and a regions (Table S4).
RNA pull-down assay
RNA folding and pull-down assays were performed as previously described (Zheng et al., 2015). Synthetic 50-biotinylated Sm4G and
Sm4Gmut RNA oligonucleotides (Integrated DNA technologies) were diluted to 5 mM in folding buffer (20 mM Tris-HCl pH 7.6, 1 mM
EDTA and 100 mMKCl or 100 mM LiCl), heated at 95C for 5 min and then allowed to cool at room temperature. To confirm the pres-
ence of G4 RNA, circular dichroism (CD) spectra were obtained in a Chirascan CD Spectrometer (Applied Photophysics Limited) at
25C, with wavelength scan range of 220-320 nm and path length of 1 mm. Spectra were subtracted for buffer controls and smooth-
ing was performed using Prism software. Alternatively, 10 pmoles of Sm4G-KCl, Sm4G-LiCl, Sm4Gmut-LiCl or Sm4Gmut-KCl were
resolved in a 6% TBE agarose gel, transferred to a positively charged nylon membrane (Hybond N+) in 0.5x TBE at 30V for 1 hr. After
UV-crosslinking, biotinylated RNA on the membrane was detected with HRP-conjugated Streptavidin (ThermoScientific) in TBST,
5% BSA. For RNA pull-down, whole cell extracts where prepared from CH12 cells cultured at a density of 0.06 3 106 cells per
mL in CIT stimulated conditions for 48 hr. RIPA lysis buffer without glycerol andwith 2mMEDTAwas used. Extracts were pre-cleared
at 4C for 1 hr with Streptavidin MagneSphere Paramagnetic beads (Promega). Pre-cleared lysate (the equivalent to 1x106 cells) wase6 Molecular Cell 70, 650–662.e1–e8, May 17, 2018
diluted with an equal volume of 2x Binding buffer (50mMTris-Acetate pH 7.8,10mMNaCl, 3mMMgCl2, 70mMglycine, 10%glycerol
containing 100 mM KCl or 100 mM LiCl) and incubated with biotinylated oligonucleotides (200 pmol) for 1 hr at room temperature.
Streptavidin MagneSphere Paramagnetic beads (Promega) were then added and incubated for an additional 1 hr. Beads were
washed thrice with RIPA and once with PBS before bound proteins were recovered in 2x SDS loading buffer (5 min at 65C plus
boiling at 95C) and analyzed by immunoblot. Bound RNAs were recovered by incubating beads in Trizol (ThermoFischer) and
analyzed by dot blot using HRP-conjugated Streptavidin.
Electromobility Shift Assay (EMSA)
Synthetic oligonucleotides (12.5 pmols, Integrated DNA Technologies; (Creacy et al., 2008; Dickerson et al., 2003; Zheng et al., 2015))
were 50 end labeled by phosphorylation with [g-32P]ATP and T4 polynucleotide kinase (PNK, NEB) for 1 h at 37 C. Radiolabeled RNA
was purified in a MicroSpin G-25 column (GE Healthcare) and precipitated in 0.3M sodium acetate, pH 5.2 and three volumes of
ethanol. After centrifugation and a washing step with 70% ethanol the labeled oligos were resuspended in 200 mL of nuclease-
free water (Ambion) and RNAwas quantified by scintillation counting. Binding reactions were performed at 25C for 10 min by mixing
1, 2 or 4 mg recombinant human DDX1 protein (amino acids 1-728 (Kellner et al., 2015); diluted to 0.25, 0.5 or 1 mg/mL in 10 mM
HEPES-NaOH pH 7.9, 250 mM KCl, 5 mM MgCl2, 3 mM DTT) with 1 mL labeled oligo in a 20 mL final volume. Reactions were per-
formed in binding buffer (10.4 mM HEPES-NaOH pH 7.9, 2 mM MgCl2, 1.6 mM MgAc, 1 mM DTT, 7.6% glycerol, 1.5 mM ATP
and 2 mM GTP) and resolved on a native 4% polyacrylamide gel (19:1) at 25 mAmp for 3h in 1 3 running buffer (75 mM Tris-HCL,
75 mM glycine pH 7.5-7.7) buffer at 4 C. The gel was then dried on 3 MMWhatman filter paper and exposed with autoradiographic
XAR film (Kodak).
In vitro RNA:DNA hybrid assay
Tetramolecular G4 RNA forming oligonucleotides (Creacy et al., 2008) (Dharmacon) were annealed in 10 mM Tris-HCl pH 8, 50 mM
KCl buffer at a concentration of 100 mM, after heating at 99C for 20 min and slowly cooling to 4C over several hours. 50 end labeling
of G4RNA followed byMicroSpin G-25 column purification was performed as described before. G4 RNAwas further purified by elec-
trophoresis on a native 12%polyacrylamide gel, band excision and elution in 0.5MNaOAc, 1 mMEDTA and 0.1%SDS buffer for 3 hr
at 4C. After ethanol precipitation, G4 RNA was resuspended in nuclease-free water and quantified by scintillation counting. In vitro
formation of RNA:DNA hybrids was determined by mixing 1 mg recombinant human DDX1 protein (amino acids 1-728, (Kellner et al.,
2015); diluted to 1 mg/mL in 10 mMHEPES-NaOH pH 7.9, 250 mM KCl, 5 mMMgCl2, 3 mM DTT) with approximately 2.5 fmol labeled
G4 RNA and an equivalent amount of complementary DNA strands (Sigma-Aldrich) in a 20 mL final volume. The reaction was per-
formed in binding buffer containing 5 mM MgCl2 and 5 mM ATP at 25C for 10, 20 or 30 min. The presence of RNA:DNA hybrids
was confirmed by treatment with 0.5 U RNaseH (Roche) for 20 min at 37C in a final concentration of 10 mM MgCl2 and 50 mM
NaCl. Nucleic acids were resolved on a native 12% polyacrylamide gel (19:1) at 100 V for 1 h 15 min in 1 3 TBE buffer at 4 C.
The gel was exposed with a phosphor screen (Fujifilm) at 80 C.
Immunofluorescence assay
Approximately 2x106 cells were fixedwith PBS, 4%PFA and permeabilized with PBS, 0.25%Triton X-100. Before staining, cells were
incubated in block buffer (PBS, 3%BSA) for 30min at room temperature. Primary antibody anti-AID (Cell Signaling, clone 30F12) was
added at 1:100 for 2 h at 4C. Cells were washed 3x in wash buffer (PBS, 0.05% Tween20) by centrifugation (700 g at 4C for 5 min).
Secondary antibody Alexa Fluor 488-conjugated anti-rabbit IgG (ThermoFischer) was added at 1:500 for 1 hr at room temperature.
Cells were washed 3x in wash buffer (PBS, 0.05% Tween20) and 2x in PBS by centrifugation (700 g at 4C for 5 min). Cell slides were
prepared by cytospin andmounted with Vectashield mountingmedia with DAPI (Vector Laboratories). Z stack images were collected
with a FluoView1000 confocal microscope (Olympus) using a UPLSAPO 60.0X / 1.35 oil objective. Images were analyzed using
ImageJ and prepared using OMERO software.
Co-Immunoprecipitation
Cells were resuspended in 1x packed cell volume (PCV) of buffer A (10mMHEPES, pH 7.9, 1.5mMMgCl2, 10mMKCl) and incubated
15 min on ice, followed by cell disruption using a 25G needle. After centrifugation (900 g at 4C for 10 min) the nuclear pellet was
resuspended in 1x PCV buffer C (20 mM HEPES, pH 7.9, 1.5 mMMgCl2, 420 mM NaCl, 25% glycerol), vortexed 10x and incubated
30min at 4Con a rotating wheel. Subsequently, nuclear lysates were diluted 3x in 50mMHEPES pH 7.9, 0.1%Triton X-100 and 1 mL
Benzonase (Sigma) was added per each 100 mL lysate. Benzonase digestion was carried out at 37C for 30 min followed by centri-
fugation (17,000 g at 4C for 10 min). Protein concentration was measured using Bio-Rad Protein Assay and 200 mg of nuclear lysate
was used per immunoprecipitation in a final volume of 500 mL IP buffer (50 mMHEPES pH 7.9, 0.1% Triton X-100, 150mMNaCl) with
1.5 mg anti-DDX1 (ProteinTech) or rabbit IgG (Sigma). Immunoprecipitation reactions were incubated at 4C overnight on a rotating
wheel, followed by 2 hr with M280 anti-rabbit IgG Dynabeads (ThermoFischer). Beads were washed 3x with IP buffer and protein
complexes were eluted in 15 mL 0.2 M Glycine pH 2.6 (10 min at room temperature). Eluates were neutralized with 5 mL 1M
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Sm mutations and microhomology analysis at Sm-Sa junctions
Genomic DNAwas isolated and recombined Sm-Sa sequences were amplified by PCR (35 cycles of 98C 10 s, 68C 2min 30 s) using
high fidelity PrimeSTARHSDNA Polymerase (Tanaka) (see Table S4 for primer sequences). PCR products spanning 1–2 kb were gel-
extracted with QiaexII gel extraction kit (QIAGEN) and cloned using StrataClone Blunt PCR cloning kit (Agilent). DNA from individual
clones was sequenced with T7 and T3 primers and NCBI blast was used for sequence alignment with germline switch sequences
(obtained fromGenome Reference ConsortiumMouse Build 38). Sm sequences were analyzed for mutation frequency as the number
of individual mutations at each nucleotide out of the total number of nucleotides analyzed per experiment. The length of microhomol-
ogy (MH) at Sm–Sa junctions was measured as the number of consecutive nucleotides with perfect homology. Insertions were
defined as nucleotides at the breakpoints with no homology to either of the S-regions. Only Sm–Sa sequences with a unique pattern
of Sm mutation were considered for these analyses.
QUANTIFICATION AND STATISTICAL ANALYSIS
ChRNA-seq data processing and bioinformatics analysis
Chromatin-associated RNA (chRNA) sequencing reads were aligned to the mouse genome (mm10), obtained from University of Cal-
ifornia at Santa Cruz (UCSC) using BWA (Li and Durbin, 2009) with default parameters. Prior to alignment, adaptor sequences were
trimmed using Cutadapt 1.8.3 (Martin, 2011), discarding reads with less than 10 bases. An in-house Perl script was used to remove
the reads left unpaired. Only uniquely aligned reads with no more than two mismatches were kept for further analysis. Data were
scaled to library size (genomeCoverageBed) using Bedtools (Quinlan and Hall, 2010). Bigwig track files were generated from the
BWA output files using UCSC bedGraphToBigWig tool (Kent et al., 2002). Gene annotation information was downloaded from the
UCSC table browser for Refseq Genes. Cufflinks 2.2.0 (Trapnell et al., 2012) was used for abundance estimation and quantification
of transcripts. Differentially expressed genes between shCtrl and shDDX1 in unstimulated (UNS) or anti-CD40, IL-4 and TGF-b (CIT)
stimulation conditions were identified using Cuffdiff 2.0.2. We included two biological replicates for each condition analyzed. A heat-
map was generated with the R-package gplots using a subset of significantly altered genes (fold-changeR 2, False discovery rate
(FDR) % 0.05) identified by differential gene expression in either shCtrl/shDDX1 or UNS/CIT comparisons. Expression values for
these genes were log transformed and quantile normalized before plotting the heatmap with rows denoting genes and columns de-
noting sample conditions.
Statistical analysis
Statistical details of experiments are described in the figure legends. Results are expressed as mean values and standard deviation
(SD) and n corresponds to the number of independent experiments. Statistical significance was analyzed using a two-tailed Stu-
dent’s t test and a paired test was used when samples were normalized. A Fisher’s exact test was used for the analyses of micro-
homology length at Sm-Sa junctions (Figure S7C). *p% 0.05 and **p% 0.01 were considered significant.
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